Dysregulation of Platelet-von Willebrand Factor Interaction in Trauma-Induced Coagulopathy
创伤性凝血病中血小板-血管性血友病因子相互作用的失调
基本信息
- 批准号:10559557
- 负责人:
- 金额:$ 15.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:ADAMTSAcetylcysteineActinsAdhesionsAdhesivenessAdhesivesAffectAnimal ModelBindingBloodBlood Coagulation DisordersBlood PlateletsBlood VesselsBlood flowBlood specimenBrain InjuriesCareer MobilityCause of DeathCell membraneCessation of lifeClinicalComplexComplicationConsumptionDataDefectDepositionDiagnosisDiagnosticDiseaseDisintegrinsEndothelial CellsFibrin split productsFibrinogenFunctional disorderGelsolinGoalsHemorrhageHemostatic functionImaging DeviceImpairmentInjuryIntegrinsInvestigationKnowledgeLeadLearningLigandsLinkMalignant NeoplasmsMeasurementMeasuresMechanicsMentorsMetalloproteasesMicrocirculationModelingMorbidity - disease rateMyocardial IschemiaOutcomeOxidative StressPathway interactionsPatientsPeptide HydrolasesPerfusionPlasmaPlatelet ActivationPlatelet AdhesivenessPlatelet aggregationPolymersProcessProfessional CompetenceProteinsRattusResearchResearch PersonnelSamplingScientistShockStructureSurfaceSyndromeTechniquesTestingTherapeutic InterventionThrombosisThrombospondinsThrombusTissuesTrainingTraumaTrauma patientUltrasonographyUnited StatesWorkacronymsburden of illnesscareercontrast enhanceddisability-adjusted life yearsempowermentexperimental studyimprovedimproved outcomein vivoinjuredinsightknowledge basemembermortalitymultidisciplinaryoxidationplatelet functionpolymerizationpreventable deathreceptorsevere injuryskillstrauma induced coagulopathyultrasoundvon Willebrand Factor
项目摘要
PROJECT SUMMARY/ABSTRACT
The overall goal of this project is to improve the outcomes of injured patients with trauma-induced coagulopa-
thy (TIC), both by performing detailed investigation of the mechanisms underlying this disorder and by providing
a junior clinician-scientist the training required to continue this work as an independent researcher. Trauma is
the leading cause of disability-adjusted life-years (a measure of overall disease burden), both in the United States
and worldwide. In trauma patients, hemorrhage is the leading cause of potentially preventable death. TIC is a
common complication of serious injury that impairs normal hemostasis and contributes to the burden of death
from hemorrhage. Two prominent features of TIC are impairment of platelet adhesion and aggregation function
and derangement of microvascular blood flow. The causes of these abnormalities are not known, but preliminary
data suggest several possible contributors. First, trauma patients have changes in their plasma von Willebrand
factor (VWF) profiles that suggest high levels of endothelial cell activation and VWF secretion. Second, trauma
patients have high levels of oxidative stress, which is known to make VWF hyperadhesive. Third, trauma patients
have low levels of gelsolin, a protein that normally solubilizes actin polymers, which can obstruct microvascular
blood flow and promote thrombus formation. Other disease states that involve similar pathways have associated
microthrombus formation leading to microvascular blood flow changes similar to those seen in TIC. Finally, three
key surface receptors that serve as mechanical anchors for platelets (GPIbα, αIIbβ3, and GPVI) show alterations
in number and structure. Together, this suggests that the VWF-platelet adhesion axis mechanistically contrib-
utes to platelet function impairment and microcirculation derangement through microvascular thrombosis and
platelet receptor cleavage or occupancy. This project includes a set of experiments to elucidate the underlying
causes of the platelet and microvascular changes of TIC. In Aim 1, the defects in the VWF-platelet adhesion
axis will be characterized by detailed study of the changes that occur with VWF, its primary cleaving protein
(ADAMTS13), and platelet adhesiveness in trauma patient blood samples. Aim 2 will characterize the alterations
of platelet receptors GPIbα, αIIbβ3, and GPVI seen in TIC by testing for receptor occupancy and for receptor
cleavage and loss in trauma patient samples. Aim 3 will evaluate the effects of agents that decrease VWF-
platelet adhesion and actin polymerization on microvascular blood flow and clinical outcomes using contrast-
enhanced ultrasound in a rat model of TIC. In addition to filling critical knowledge gaps in the pathophysiology
of TIC, this project will allow the PI to develop advanced research career skills. Under a multidisciplinary team
of expert mentors, the PI will gain a comprehensive conceptual and practical knowledge base in primary hemo-
stasis, learn how to apply a powerful ultrasound imaging tool in an animal model, and complete career advance-
ment activities to generate a unique expertise that will empower his future research. Ultimately, this project will
both advance our knowledge of TIC and catalyze a junior investigator's transition to independence.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander St. John其他文献
Alexander St. John的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander St. John', 18)}}的其他基金
Dysregulation of Platelet-von Willebrand Factor Interaction in Trauma-Induced Coagulopathy
创伤性凝血病中血小板-血管性血友病因子相互作用的失调
- 批准号:
10352212 - 财政年份:2020
- 资助金额:
$ 15.24万 - 项目类别:
Dysregulation of Platelet-von Willebrand Factor Interaction in Trauma-Induced Coagulopathy
创伤性凝血病中血小板-血管性血友病因子相互作用的失调
- 批准号:
9888677 - 财政年份:2020
- 资助金额:
$ 15.24万 - 项目类别:
相似海外基金
抗酸化能を高めたN-acetylcysteineによる老視と白内障抑制機構の解明
阐明具有增强抗氧化能力的N-乙酰半胱氨酸抑制老花眼和白内障的机制
- 批准号:
23K15945 - 财政年份:2023
- 资助金额:
$ 15.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
- 批准号:
10758985 - 财政年份:2023
- 资助金额:
$ 15.24万 - 项目类别:
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
- 批准号:
10619173 - 财政年份:2022
- 资助金额:
$ 15.24万 - 项目类别:
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
- 批准号:
10517287 - 财政年份:2021
- 资助金额:
$ 15.24万 - 项目类别:
A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder
N-乙酰半胱氨酸治疗酒精使用障碍的随机对照试验
- 批准号:
nhmrc : 2001375 - 财政年份:2021
- 资助金额:
$ 15.24万 - 项目类别:
Clinical Trials and Cohort Studies Grants
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
- 批准号:
10368472 - 财政年份:2021
- 资助金额:
$ 15.24万 - 项目类别:
N-acetylcysteineの骨治癒促進効果の検討
N-乙酰半胱氨酸促进骨愈合作用的考察
- 批准号:
20H01118 - 财政年份:2020
- 资助金额:
$ 15.24万 - 项目类别:
Grant-in-Aid for Encouragement of Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
- 批准号:
10221760 - 财政年份:2020
- 资助金额:
$ 15.24万 - 项目类别:














{{item.name}}会员




